Search Results - "BONILLA, M. A"
-
1
Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy
Published in Journal of clinical oncology (01-05-1996)“…To test intensive alkylator-based therapy in desmoplastic small round-cell tumor (DSRCT). Patients received the P6 protocol, which has seven courses of…”
Get more information
Journal Article -
2
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
Published in Blood (15-07-2000)“…Granulocyte colony-stimulating factor (G-CSF) has had a major impact on management of "severe chronic neutropenia," a collective term referring to congenital,…”
Get full text
Journal Article -
3
Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias
Published in British journal of haematology (01-12-1994)“…Congenital neutropenias include a heterogenous group of diseases characterized by a decrease in circulating neutrophils. In phase I/II/III studies in patients…”
Get more information
Journal Article -
4
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia
Published in Leukemia (1997)“…Previously, nonsense mutations in the gene encoding the granulocyte colony-stimulating factor receptor (G-CSF-R) have been described in three patients with…”
Get full text
Journal Article -
5
Antibiotic‐resistant Staphylococcus aureus strains of swine origin: molecular typing and susceptibility to oregano (Origanum vulgare L.) essential oil and maqui (Aristotelia chilensis (Molina) Stuntz) extract
Published in Journal of applied microbiology (01-10-2019)“…Aim The molecular typing and the susceptibility of Staphylococcus aureus strains of swine origin to antibiotics, oregano (Origanum vulgare L.) essential oil…”
Get full text
Journal Article -
6
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age
Published in Journal of clinical oncology (01-12-1994)“…To test the efficacy of a protocol for poor-risk neuroblastoma that builds on the following: (1) our favorable previously reported results with dose-intensive…”
Get more information
Journal Article -
7
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy
Published in Journal of clinical oncology (01-02-1996)“…To test the hypothesis that cytotoxic therapy is not needed at diagnosis to assure the survival of most patients with non-stage 4 neuroblastoma. Patients with…”
Get more information
Journal Article -
8
A Randomized Controlled Phase III Trial of Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) for Treatment of Severe Chronic Neutropenia
Published in Blood (15-05-1993)“…Patients with idiopathic, cyclic, and congenital neutropenia have recurrent severe bacterial infections. One hundred twenty-three patients with recurrent…”
Get full text
Journal Article -
9
Monosomy 7 and Activating RAS Mutations Accompany Malignant Transformation in Patients With Congenital Neutropenia
Published in Blood (15-12-1995)“…Individuals with severe forms of congenital neutropenia suffer from recurrent infections. The therapeutic use of recombinant human granulocyte…”
Get full text
Journal Article -
10
Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates
Published in The Journal of experimental medicine (01-04-1987)“…We examined the in vivo effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in primates (cynomolgus monkeys) treated with subcutaneous…”
Get full text
Journal Article -
11
Chemotactic Activity of Recombinant Human Granulocyte Colony-Stimulating Factor
Published in Blood (01-11-1988)“…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) induced migration across polycarbonate filters of human polymorphonuclear leukocytes (PMN)…”
Get full text
Journal Article -
12
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium
Published in The Journal of clinical investigation (01-10-1988)“…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60 micrograms/kg of body weight to 22 patients with…”
Get full text
Journal Article -
13
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review
Published in Journal of clinical oncology (01-07-1996)“…To gain insight into the management of non-metastatic neuroblastoma by examining clinical and biologic features of International Neuroblastoma Staging System…”
Get more information
Journal Article -
14
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis
Published in The New England journal of medicine (15-06-1989)“…Congenital agranulocytosis is a disorder characterized by severe neutropenia and a profound deficiency of identifiable neutrophil progenitors in bone marrow…”
Get more information
Journal Article -
15
Entomofauna resource distribution associated with pig cadavers in Bogotá DC
Published in Medical and veterinary entomology (01-03-2011)“…A cadaver represents a temporal energy-loaded resource, which provides arthropods with food, protection and a place in which to find a mate. Insects are…”
Get full text
Journal Article -
16
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia
Published in Blood (01-10-2000)“…Congenital neutropenia and cyclic neutropenia are disorders of neutrophil production predisposing patients to recurrent bacterial infections. Recently the…”
Get full text
Journal Article -
17
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers
Published in European journal of cancer (1990) (01-10-1997)“…The clinical characteristics of 43 patients (pts) and the biological features of their non-stage 4 neuroblastoma (11, 3, 15, 7 and 7 with stages 1, 2A, 2B, 3…”
Get full text
Journal Article -
18
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age
Published in Journal of clinical oncology (01-09-1998)“…To eradicate minimal residual disease with anti-G(D2) monoclonal antibody 3F8 in stage 4 neuroblastoma (NB) diagnosed at more than 1 year of age. Thirty-four…”
Get more information
Journal Article -
19
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia
Published in The New England journal of medicine (05-01-1989)Get more information
Journal Article -
20
Taenia crassiceps Cysticercosis: Humoral Immune Response and Protection Elicited by DNA Immunization
Published in The Journal of parasitology (01-06-1998)“…The purpose of this study was to evaluate DNA vaccination in cysticercosis prevention by using a Taenia crassiceps cDNA of a recombinant antigen (KETc7) that…”
Get full text
Journal Article